![Tamar Ben-Yedidia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tamar Ben-Yedidia
Hoofd Techniek/Wetenschap/O&O bij
BIONDVAX PHARMACEUTICALS LTD
Profiel
Tamar Ben-Yedidia currently works at Scinai Immunotherapeutics Ltd., as Chief Science Officer from 2004.
Dr. Ben-Yedidia also formerly worked at Biotechnology General (Israel) Ltd., as Lab Manager from 1991 to 1994.
Dr. Ben-Yedidia received her undergraduate degree from Tel-Aviv University and doctorate degree in 2000 from Weizmann Institute of Science.
Actieve functies van Tamar Ben-Yedidia
| Bedrijven | Functie | Begin |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Hoofd Techniek/Wetenschap/O&O | 01-01-2004 |
Eerdere bekende functies van Tamar Ben-Yedidia
| Bedrijven | Functie | Einde |
|---|---|---|
Biotechnology General (Israel) Ltd.
 Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | 01-01-1994 |
Opleiding van Tamar Ben-Yedidia
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
42
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Scinai Immunotherapeutics Ltd.
 Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
